Hims & Hers Health (HIMS) Preferred Stock Liabilities (2019 - 2020)
Hims & Hers Health's (HIMS) quarterly Preferred Stock Liabilities came in at $250.0 million in Q4 2020, up 5454.71% year-on-year from $4.5 million in Q1 2020, and up 1.96% quarter-over-quarter from $245.2 million in Q3 2020.
Hims & Hers Health (HIMS) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends
Hims & Hers Health has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $250.0 million for Q4 2020.
- Preferred Stock Liabilities for Q4 2020 came in at $250.0 million, up 5454.71% year-over-year; the trailing twelve-month figure through Dec 2020 was $250.0 million (up 5454.71% YoY), and the FY2020 annual result was $250.0 million, up 5454.71% from the prior year.
- Preferred Stock Liabilities came in at $250.0 million for Q4 2020 at Hims & Hers Health, up from $245.2 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $250.0 million in Q4 2020 to a low of $4.5 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 249.96 Mn |
| Sep 30, 2020 | 245.17 Mn |
| Jun 30, 2020 | 228.13 Mn |
| Mar 31, 2020 | 218.25 Mn |
| Dec 31, 2019 | 4.50 Mn |